Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated July 14, 2021, titled "CAPLIN STERILES GETS USFDA APPROVAL FOR SUMATRIPTAN INJECTION".
Press Release Jul 14 2021
Filed with NSE ·
6ix hasn’t read this filing yet.
Caplin Point Laboratories Limited on 6ix
Earlier from Caplin Point Laboratories
- Press Release Apr 23 2021
- Press Release Apr 22 2021
- Press Release Apr 19 2021
- Press Release Jan 22 2021
- Press Release Jan 18 2021
Later from Caplin Point Laboratories
- Press Release Aug 17 2021
- Press Release Sep 08 2021
- Press Release Sep 24 2021
- Press Release Aug 22 2022
- Press Release Feb 14 2023
Follow Caplin Point Laboratories into a list and get an email when it puts out news.
Follow Caplin Point Laboratories